Literature DB >> 34983192

Recent advances in the application of nanomedicine for the treatment of diabetes.

Hari Priya Vemana1, Vikas V Dukhande1.   

Abstract

Entities:  

Keywords:  artificial pancreas; diabetes; gene therapy; glucose sensor; immunotherapy; insulin; nanotechnology; stem-cell therapy

Mesh:

Substances:

Year:  2022        PMID: 34983192      PMCID: PMC8765109          DOI: 10.2217/nnm-2021-0338

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


× No keyword cloud information.
  28 in total

Review 1.  Nanotechnology's application in Type 1 diabetes.

Authors:  Wen Pan; Xueying Zheng; Guiyuan Chen; Lanhong Su; Sihui Luo; Wei Wang; Shandong Ye; Jianping Weng; Yuanzeng Min
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-05-22

2.  Glucose-Responsive Nanoparticles for Rapid and Extended Self-Regulated Insulin Delivery.

Authors:  Lisa R Volpatti; Morgan A Matranga; Abel B Cortinas; Derfogail Delcassian; Kevin B Daniel; Robert Langer; Daniel G Anderson
Journal:  ACS Nano       Date:  2019-12-20       Impact factor: 15.881

3.  Potential Use of Exosomes as Diagnostic Biomarkers and in Targeted Drug Delivery: Progress in Clinical and Preclinical Applications.

Authors:  Md Nurul Huda; Md Nafiujjaman; Isaac G Deaguero; Jude Okonkwo; Meghan L Hill; Taeho Kim; Md Nurunnabi
Journal:  ACS Biomater Sci Eng       Date:  2021-05-14

Review 4.  Nanotechnology in cell replacement therapies for type 1 diabetes.

Authors:  Alexander U Ernst; Daniel T Bowers; Long-Hai Wang; Kaavian Shariati; Mitchell D Plesser; Natalie K Brown; Tigran Mehrabyan; Minglin Ma
Journal:  Adv Drug Deliv Rev       Date:  2019-02-02       Impact factor: 15.470

Review 5.  Advances in β-cell replacement therapy for the treatment of type 1 diabetes.

Authors:  Marie-Christine Vantyghem; Eelco J P de Koning; François Pattou; Michael R Rickels
Journal:  Lancet       Date:  2019-09-15       Impact factor: 79.321

6.  Engineering Strategies to Improve Islet Transplantation for Type 1 Diabetes Therapy.

Authors:  Alisa M White; James G Shamul; Jiangsheng Xu; Samantha Stewart; Jonathan S Bromberg; Xiaoming He
Journal:  ACS Biomater Sci Eng       Date:  2019-12-02

7.  β-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells.

Authors:  Lina Sui; Nichole Danzl; Sean R Campbell; Ryan Viola; Damian Williams; Yuan Xing; Yong Wang; Neil Phillips; Greg Poffenberger; Bjarki Johannesson; Jose Oberholzer; Alvin C Powers; Rudolph L Leibel; Xiaojuan Chen; Megan Sykes; Dieter Egli
Journal:  Diabetes       Date:  2017-09-20       Impact factor: 9.337

8.  Lipid nanoparticle delivery of glucagon receptor siRNA improves glucose homeostasis in mouse models of diabetes.

Authors:  Ursula H Neumann; Jessica S S Ho; Sam Chen; Yuen Yi C Tam; Pieter R Cullis; Timothy J Kieffer
Journal:  Mol Metab       Date:  2017-06-22       Impact factor: 7.422

Review 9.  Current progress in stem cell therapy for type 1 diabetes mellitus.

Authors:  Shuai Chen; Kechen Du; Chunlin Zou
Journal:  Stem Cell Res Ther       Date:  2020-07-08       Impact factor: 6.832

10.  Lecithin nano-liposomal particle as a CRISPR/Cas9 complex delivery system for treating type 2 diabetes.

Authors:  Eun Yi Cho; Jee-Yeon Ryu; Han A Reum Lee; Shin Hee Hong; Hye Sun Park; Kwan Soo Hong; Sang-Gyu Park; Hong Pyo Kim; Tae-Jong Yoon
Journal:  J Nanobiotechnology       Date:  2019-01-29       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.